Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1602

Mar 26, 2020

Israel preparing to use unapproved medication to treat coronavirus

Posted by in category: biotech/medical

As for coronavirus patients in serious condition, the ministry proposed – in addition to treating respiratory failure and supportive treatment – using Gilead’s drug Remdesivir, which was used in the case of Patient 16. The 38-year-old bus driver from East Jerusalem was in serious condition and the drug improved his situation dramatically, so much so that he was in good condition after the treatment.


They said that research into treating the virus is only in the research stage since the virus was only discovered some months ago.

Mar 26, 2020

Israeli scientist’s shrimp antiviral could be adapted for coronavirus

Posted by in categories: biotech/medical, engineering, food

The 43-year-old scientist is a member of the Technion’s Wolfson Faculty of Chemical Engineering, and his lab first developed a food additive to boost the immune system of animals to protect them from contracting viral diseases. This invention formed the basis of his own commercialized start-up company, ViAqua Therapeutics, which focused the development of the drug on shrimp, as over 30% of the global shrimp population is wiped out yearly by a viral disease known as white spot syndrome.


Israeli scientist and entrepreneur Prof. Avi Schroeder is working on a preventative drug for the coronavirus by adapting a food additive designed for shrimp.

Continue reading “Israeli scientist’s shrimp antiviral could be adapted for coronavirus” »

Mar 26, 2020

Former Taiwan Premier Offers Lessons on How the U.S. Should Deal With COVID-19

Posted by in categories: biotech/medical, health

The last point is that Taiwan has a very good healthcare system, especially compared with the U.S. Taiwan’s health insurance system is affordable for the general public, which means everyone can get a medical examination or hospital treatment when necessary. It is also a scientific one: The health insurance system collects personal data and medical records, so hospitals and doctors can make good judgments about every patient’s condition. The quality of the national health system is quite important in the healing of patients and the containment of coronavirus.


Taiwan’s coronavirus response so far has been exemplary. Other nations, especially the U.S., should take note, says former Taiwan Premier Jiang Yi-huah.

Mar 26, 2020

The COVID-19 vaccine race

Posted by in category: biotech/medical

The race is on to find both medicines and vaccines for the COVID-19 pandemic. Countries around the world are using different vaccine technologies to try and find one that could stop the pandemic.

Mar 26, 2020

Coronavirus Update (Live): 523,892 Cases and 23,647 Deaths from COVID-19 Virus Outbreak

Posted by in category: biotech/medical

Live statistics and news tracking the number of confirmed cases, recovered patients, and death toll by country due to the COVID 19 from Wuhan, China. counter with new cases, historical data, and info. Daily charts, graphs, news and updates.

Mar 26, 2020

101-Year-Old Man Who Survived 1918 Flu Beats Coronavirus, Too

Posted by in category: biotech/medical

A beacon of hope.

Mar 26, 2020

Epidemiologist Behind Highly-Cited Coronavirus Model Drastically Revises Model

Posted by in categories: biotech/medical, policy

Epidemiologist Neil Ferguson, who created the highly-cited Imperial College London coronavirus model, which has been cited by organizations like The New York Times and has been instrumental in governmental policy decision-making, offered a massive revision to his model on Wednesday.

Ferguson’s model projected 2.2 million dead people in the United States and 500,000 in the U.K. from COVID-19 if no action were taken to slow the virus and blunt its curve.

However, after just one day of ordered lockdowns in the U.K., Ferguson is presenting drastically downgraded estimates, revealing that far more people likely have the virus than his team figured. Now, the epidemiologist predicts, hospitals will be just fine taking on COVID-19 patients and estimates 20,000 or far fewer people will die from the virus itself or from its agitation of other ailments, as reported by New Scientist Wednesday.

Mar 26, 2020

WSCS16 — Day 3 — The Future of Human Aging

Posted by in categories: biotech/medical, life extension

The Future of Human Aging: Implications of Induced Tissue Regeneration (iTR), with Michael D. West, Ph.D., Co-CEO of BioTime.

Mar 26, 2020

French lab offers ‘millions of doses’ of Covid-19 drug

Posted by in category: biotech/medical

A French medical laboratory has said it is ready to give the French authorities “millions of doses” of an anti-malaria medication that early tests have suggested may help cure Covid-19.

Mar 26, 2020

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

Posted by in categories: biotech/medical, surveillance

The initial cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, Hubei Province, China, in December 2019 and January 2020. We analyzed data on the first 425 confirmed cases in Wuhan to determine the epidemiologic characteristics of NCIP.


Since December 2019, an increasing number of cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) have been identified in Wuhan, a large city of 11 million people in central China.1–3 On December 29, 2019, the first 4 cases reported, all linked to the Huanan (Southern China) Seafood Wholesale Market, were identified by local hospitals using a surveillance mechanism for “pneumonia of unknown etiology” that was established in the wake of the 2003 severe acute respiratory syndrome (SARS) outbreak with the aim of allowing timely identification of novel pathogens such as 2019-nCoV.4 In recent days, infections have been identified in other Chinese cities and in more than a dozen countries around the world.5 Here, we provide an analysis of data on the first 425 laboratory-confirmed cases in Wuhan to describe the epidemiologic characteristics and transmission dynamics of NCIP.